Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$844M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$807M |
| 3 |
Merck
MRK
|
+$531M |
| 4 |
CRH
CRH
|
+$462M |
| 5 |
Amazon
AMZN
|
+$431M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.54B |
| 2 |
Microsoft
MSFT
|
+$1B |
| 3 |
NVIDIA
NVDA
|
+$651M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$569M |
| 5 |
Micron Technology
MU
|
+$470M |
Sector Composition
| 1 | Technology | 17.02% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 11.94% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Century Communities
CCS
$2B
| $11.4M | ﹤0.01% |
117,977
+88,727
| +303% | +$8.56M |
|
|
NVRO
1327
DELISTED
NEVRO CORP.
NVRO
| $11.4M | ﹤0.01% |
787,969
-82,111
| -9% | -$1.19M |
|
1328
Sweetgreen
SG
$1B
| $11.4M | ﹤0.01% |
449,664
-1,161,674
| -72% | -$29.3M |
|
1329
Steven Madden
SHOO
$2.26B
| $11.3M | ﹤0.01% |
267,909
+188,264
| +236% | +$7.96M |
|
1330
ADMA Biologics
ADMA
$3.84B
| $11.3M | ﹤0.01% |
1,710,021
-1,741,846
| -50% | -$11.5M |
|
1331
Perion Network
PERI
$418M
| $11.3M | ﹤0.01% |
501,250
-146,489
| -23% | -$3.29M |
|
1332
HilleVax
HLVX
$105M
| $11.3M | ﹤0.01% |
+676,566
| New | +$11.3M |
|
1333
Verra Mobility
VRRM
$3.92B
| $11.2M | ﹤0.01% |
449,378
+366,966
| +445% | +$9.16M |
|
1334
EastGroup Properties
EGP
$8.9B
| $11.2M | ﹤0.01% |
62,345
-121,026
| -66% | -$21.8M |
|
1335
B2Gold
BTG
$5.94B
| $11.2M | ﹤0.01% |
4,282,089
+3,120,893
| +269% | +$8.15M |
|
1336
Vesta Real Estate
VTMX
$2.37B
| $11.2M | ﹤0.01% |
284,915
+107,251
| +60% | +$4.21M |
|
1337
Chemed
CHE
$6.5B
| $11.2M | ﹤0.01% |
17,370
-27,512
| -61% | -$17.7M |
|
1338
Varex Imaging
VREX
$469M
| $11.1M | ﹤0.01% |
615,442
-241,856
| -28% | -$4.38M |
|
1339
Duke Energy
DUK
$94.8B
| $11.1M | ﹤0.01% |
114,981
+77,140
| +204% | +$7.46M |
|
1340
Albany International
AIN
$1.71B
| $11.1M | ﹤0.01% |
118,768
+105,045
| +765% | +$9.82M |
|
1341
Innospec
IOSP
$2.05B
| $11.1M | ﹤0.01% |
85,879
+25,709
| +43% | +$3.31M |
|
1342
FTI Consulting
FCN
$5.32B
| $11.1M | ﹤0.01% |
52,560
+20,617
| +65% | +$4.34M |
|
1343
Integral Ad Science
IAS
$1.4B
| $11M | ﹤0.01% |
1,104,398
-3,948,576
| -78% | -$39.4M |
|
1344
Lazard
LAZ
$5.25B
| $11M | ﹤0.01% |
+262,919
| New | +$11M |
|
1345
Vertex
VERX
$3.84B
| $11M | ﹤0.01% |
346,544
+58,448
| +20% | +$1.86M |
|
1346
MasterBrand
MBC
$1.71B
| $11M | ﹤0.01% |
585,937
-247,560
| -30% | -$4.64M |
|
1347
Atmus Filtration Technologies
ATMU
$3.81B
| $11M | ﹤0.01% |
+340,268
| New | +$11M |
|
1348
Kimbell Royalty Partners
KRP
$1.26B
| $11M | ﹤0.01% |
706,993
-99,956
| -12% | -$1.55M |
|
1349
AtriCure
ATRC
$1.74B
| $10.9M | ﹤0.01% |
359,742
-81,436
| -18% | -$2.48M |
|
1350
Kyndryl
KD
$7.39B
| $10.9M | ﹤0.01% |
502,867
-176,240
| -26% | -$3.83M |
|